Filing Details
- Accession Number:
- 0001104659-17-022745
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-04-11 06:04:28
- Reporting Period:
- 2017-04-06
- Filing Date:
- 2017-04-11
- Accepted Time:
- 2017-04-11 06:04:28
- Original Submission Date:
- 2017-04-10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641640 | Nabriva Therapeutics Ag | NBRV | () | E9 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1232258 | Ltd. (Cayman) Investments Healthcare Hbm | Governors Square, Suite #4-212-2 23 Lime Tree Bay Ave., West Bay Grand Cayman E9 00000 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| American Depository Shares Representing Common Shares | Disposition | 2017-04-06 | 6,617 | $11.28 | 2,753,263 | No | 4 | S | Direct | |
| American Depository Shares Representing Common Shares | Disposition | 2017-04-06 | 24,600 | $11.20 | 2,728,663 | No | 4 | S | Direct | |
| American Depository Shares Representing Common Shares | Disposition | 2017-04-07 | 3,500 | $11.04 | 2,725,163 | No | 4 | S | Direct | |
| American Depository Shares Representing Common Shares | Disposition | 2017-04-07 | 18,001 | $10.96 | 2,707,162 | No | 4 | S | Direct | |
| American Depository Shares Representing Common Shares | Disposition | 2017-04-10 | 37,876 | $10.73 | 2,669,286 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Each American Depository Share of the Issuer ("ADS") represents one-tenth (1/10th) of a Common Share. The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs.
- The prices reported in Column 4 are weighted average prices. These ADSs were sold in multiple transactions. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price.
Billionaire Hedge Funds
